Boonen S, Bouillon R, Fagard K, Mullens A, Vlayen J, Vanderschueren D
Leuven University Center for Metabolic Bone Diseases.
Acta Otorhinolaryngol Belg. 2001;55(2):119-27.
There is little debate about the primacy of surgery in the management of symptomatic or complicated primary hyperparathyroidism. Rather, the question has been what to do about the many patients with nonclassical disease. Recent prospective data have confirmed that patients with asymptomatic primary hyperparathyroidism who are not surgical candidates for parathyroidectomy appear to do well when they are managed conservatively. On average, these patients remain stable, with little progression to the more serious manifestations of hyperparathyroidism over 10 years. It would seem, therefore, that the overall population of older patients with mild asymptomatic primary hyperparathyroidism can be safely followed without intervention. A certain proportion of cases do progress, however, so surveillance is necessary. Individual patients can have worsening hypercalcemia or hypercalciuria, and in a small percentage of patients, bone density may decrease over time. In most patients, deferral of surgery is not a one-time decision, but rather one that is reviewed and reconsidered in conjunction with meticulous monitoring.
在有症状或复杂的原发性甲状旁腺功能亢进症的管理中,手术的首要地位几乎没有争议。相反,问题在于如何处理许多患有非典型疾病的患者。最近的前瞻性数据证实,对于无症状的原发性甲状旁腺功能亢进症患者,如果他们不适合进行甲状旁腺切除术,保守治疗似乎效果良好。平均而言,这些患者病情保持稳定,在10年内很少进展为更严重的甲状旁腺功能亢进症表现。因此,似乎轻度无症状原发性甲状旁腺功能亢进症的老年患者总体上可以在不进行干预的情况下安全随访。然而,一定比例的病例确实会进展,所以监测是必要的。个别患者可能会出现高钙血症或高钙尿症加重,并且在一小部分患者中,骨密度可能会随时间下降。在大多数患者中,推迟手术不是一次性的决定,而是一个结合细致监测进行审查和重新考虑的决定。